Tony joined the team at Waltz Health in April 2021 as its Chief Strategy Officer. He is accountable for driving the company strategy forward through collaboration with the executive team with the goal to rewire the pharmaceutical supply chain.

Tony joined a start-up PBM called Flipt in July 2018 as its SVP Strategy, Corporate Development and Alliance Management. His responsibilities included building the supply chain platform for Flipt as well as aligning with the executive team to grow the company from a sales and partner relationship perspective.

· Responsibilities include complete management of four businesses including the profit and loss statements - businesses combine for revenue roughly $500 million · Development and ownership of the strategic direction for each business – strategy is developed collaboratively with the team to drive long-term growth in each business. Quarterly presentations to Executive management focused on past performance and strategies to drive growth through 2021. · Management of complete, stand-alone operations totaling 270 full-time employees and outside contractors. Departments managed within these businesses include sales, account management, member call center, information technology, finance, benefit administration, retail network management, implementation, and administrative personnel.Strategic Solutions encompasses the following four businesses:1) Pharmacy Discount Services (formerly known as Discount Cash Card) - the largest service provider in the cash card industry 2) Optum Hospice Pharmacy Services (formerly known as HospiScript) - the second largest service provider in the industry 3) Workers’ Compensation Processing - industry leader for back-end workers’ compensation services4) Health Business Systems - retail pharmacy systems’ provider

Chief of Staff to the OptumRx CEOResponsibilities included a wide range of tasks, including· Ownership of strategic M&A functions continued from the Catamaran role to help guide the UNH Corporate Development team to the highest priority assets and led the Corporate Development team at management meetings with prospects, presented on acquisition rationale and asset targeting, etc.· Management of weekly Executive leadership meetings including topics to discuss, preparation of speakers, analysis of activities, and overall company management discussions· Ownership of monthly performance reports including creation, preparation, approval, and delivery to corporate Executives· Ownership of quarterly earnings’ preparation documents encompassing input from leaders throughout the business and tailored specifically to answer potential investors’ questions· Preparation of sales’ presentations to strategic sales opportunities – coordination of the Executive team to deliver the appropriate message to prospects including several multi-billion-dollar opportunities· Appearances (presentations, speaking engagements, etc.) in place of the OptumRx CEO when he was unavailable including CEO collaboration meetings, internal strategic discussions, etc

Corporate Strategy• Coordinate with the Executive team to develop and drive the strategic direction of the company• Oversee the development of strategy presentations to the company and the Board of Directors• Invite outside presenters and to Executive strategic sessions to further strategic initiatives Business Development• Lead merger and acquisition (M&A) activities for the company, including owning relationships with all major investment banking and multiple private equity firms • Lead a small team to identify and analyze over 50 unique M&A assets, calculate accretion/dilution, negotiate purchase terms and valuation, present opportunities to the Executive team and to the company’s Board of Directors for approval• Led or assisted in the process of acquiring eight PBMs and one specialty pharmacy over four years deploying over $6.2 billion to acquire annualized revenues in excess of $8.2 billion • Assisted in the eventual sale of the company to the Optum division of UnitedHealth Group for $13 billion (5x increase since joining the company)Investor Relations• Manage investor relations’ functions for Catamaran, including company press releases and all investor communications and messaging delivered by the company including the CEO and CFO • Communicate with institutional investors (mutual funds, hedge funds, pension funds, etc.) and 30 publishing sell-side equity analysts regarding the industry, company, growth prospects, and financial drivers• Attend and present at 12 investor conferences per year and 10 non-deal road shows per year, developing relationships with analysts and presenting to in excess of 2,000 investors annually • 2014 Institutional Investor award winner – 2nd place for IR Professional, and 2nd place for Best Investor Relations Company in the Health Care Technology & Distribution category

Venture capital (growth equity) responsibilities• Reviewed all healthcare services related private equity investments • Led the investment process for multiple opportunities by presenting potential investment opportunities to the private equity investment group and structuring deal terms• Advised portfolio companies on the best use of capital to support company growthPublic research responsibilities (sell-side analyst)• Lead equity analyst covering nine healthcare service companies in the public market with a focus on PBMs (MHS, ESRX, CHSI, SXCI, BIOS, HMSY, AMED, LHCG, and PSSI) • Published equity investment reports, earnings models, and proprietary research reports based on company and industry research• Discussed investment opportunities with institutional buy-side portfolio managers and hosted non-deal roadshows throughout the country

• Drafted the company’s business plan and developed the business strategy including business goals, direction, target market, marketing campaigns, and capital expenditures• Fostered relationships with finance companies, hedge funds, private equity firms, and individual investors regarding their involvement as funding sources in The Funding Exchange• Successfully exited the business by selling ownership equity to investors

Outstart is a software company that purchased Participate Systems’ social networking software product. • Managed the implementation team for every installation of Participate Systems’ software product, and served as the lead sales engineer• Collaborated with a cross-functional team to design the networking management software platform

Information technology and business consulting firm focused on designing and building custom web-based applications to address supply chain management issues.• Managed team-based engagements for clients like Mack Trucks, Whirlpool, Detroit Edison, etc.